Nasal Decolonization Market Size, Share, Growth, and Industry Analysis, By Type (Nasal Mupirocin, Nasal Povidone Iodine, and other), By Application (Hospital, Retail Pharmacy, and others), Regional Insights, and Forecast From 2024 To 2031

Updated On: 20 November 2023

Nasal Decolonization Market Report Overview

• 
• Request a Free Sample to learn more about this report

The global nasal decolonization market size is USD 110.8 million in 2022 and is projected to touch USD 207.46 million by 2031, exhibiting a CAGR of 7.2% during the forecast period.

A promising opportunity that controls the infection and remains under-utilized is known as nasal decolonization. It is also called nose decolonization. It is a safe practice for evidence-based patients to reduce the risk of infection from various viruses during surgery. Most of the sinus cases are reported owing to viral and common cold infections. These infections have been classified as acute and chronic based on the severity of the infection. 

Chronic infections are the one that lasts for more than 90 days, whereas acute sinus is cured in 30 days. At the beginning of this infection, it can easily be diagnosed by inspecting it physically by its characteristics of nasal septum’s structure, presence of polyps, and nasal mucosa. Treating this infection may also require MRI, CT, or ultrasound scan. Common sinus-curing drugs include corticosteroids, antibiotics, sulfonamides, painkillers, and antihistamines. Prednisone, mometasone, fluticasone, and triamcinolone, are the most commonly used drugs for the treatment of decolonization of nasal. 

COVID-19 Impact: Rise in Health Awareness Fostered Market Growth 

The global COVID-19 pandemic has been unprecedented and staggering, with nasal decolonization experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.

Growing chronic illness cases, and the global prevalence of COVID-19 patients are contributing to the market's expansion. During the COVID-19 pandemic, optimal use of the medical infrastructure became a top priority for governments all around the world. The population was more aware of cold, cough, and nasal decolonization as it was a suspected symptom of COVID-19. The demand for the kit increased in various nursing homes, hospitals, and other facilities. The pandemic compelled the sinus therapeutic drugs market to boost the production of drugs for addressing respiratory disorders. 

LATEST TRENDS

"Constant R&D in the Antibiotics Sector to Augment Growth"

Rethinking adult acute sinusitis treatment is becoming more and more important. Drug-resistant bacteria are becoming a serious public health hazard in various countries leading to the overuse of antibiotics. Increased morbidity, death, and expense for people and healthcare systems are the results of this. As a result, businesses in the sinus or nasal decolonization treatment industry are stepping up in R&D to offer patients with better alternative approaches for treating their symptoms, which is estimated to surge nasal decolonization market growth. The second biggest gain among all therapy categories is expected to be dominated by antibiotics. However, the majority of recent studies investigating the effectiveness of antibiotics for acute sinus have excluded patients with extreme illnesses or co-existing problems such as pulmonary ailments, diabetes, and other such issues and instead have recruited generally healthy adults.

Nasal Decolonization Market Segmentation

• 
• Request a Free Sample to learn more about this report

• By Type Analysis

By type, the market is segmented into nasal mupirocin, nasal povidone-iodine, and others. 

• By Application Analysis

Based on application, the market is classified into hospitals, retail pharmacies, and others.

DRIVING FACTORS

"Rising Geriatric Population Suffering From Breathing Issues to Surge Product Demand"

The nasal decolonization market growth is expected to be backed by the rise in the number of elderly people suffering from chronic rhinosinusitis with nasal polyps (CRSwNP), the rapid adoption of minimally invasive surgeries by otorhinolaryngology’s surgeons, and the abundance of nasal polyps’ treatment options with expanding research activities. The market's expansion is hampered by the high cost of sinus surgery as well as problems such as heavy bleeding, cerebrospinal fluid leak, vision difficulties, postoperative scarring, and inflammation. 

"Various Benefits of the Product to Bolster Market Growth"

Nasal decolonization is a kit used as an antiseptic for the preparation of the skin. It helps in reducing bacterial growth that may cause skin infections in the patient. A broad-spectrum nasal decolonization kit is used for preparing the skin before surgery to keep the nasal safe. It is made for professional and hospital use and can be stored at room temperature. Its easy storage makes the industry adopt it widely. It is widely used by the healthcare industry for controlling infection among patients. It also decreases the bacterial burden and contributes to decreasing the risk of infection in staff and patients.

RESTRAINING FACTORS

"Side Effects Associated With the Product to Hamper Market Growth"

Using a nasal decolonization kit without a doctor's prescription may lead to various allergies. This kit. These factors are anticipated to impede nasal decolonization market growth in the forecast period. Additionally, side effects related to steroid therapy, such as weight gain, a loss in bone mineral density, and the development of ocular cataracts, limit market expansion.

Nasal Decolonization Market Regional Insights

• 
• Request a Free Sample to learn more about this report

"Asia Pacific to Lead the Market Due to the Expanding Healthcare Infrastructure"

Asia Pacific is expected to hold a dominating part of the nasal decolonization market share owing to the growing healthcare infrastructure in the region. Additionally, the escalating prevalence of nasal infections may also offer the opportunity for the growth of the market. 

North America is forecasted to show significant growth in the market owing to the escalating cases of sinus and other respiratory diseases. 

KEY INDUSTRY PLAYERS

"Key Players Focusing On Developing Advanced Kits to Grow in Market"

Businesses are working on developing new technology to offer more easy ways to increase product portfolio. Companies also use innovative practices and techniques to create new technologies. Companies are focused on acquisitions and investments to increase sales. The marketplace is competitive as a result of the existence of numerous huge firms. An extensive worldwide consumer base and the execution of operations through specialized distribution networks are other characteristics. The key companies strive to gain a higher market share by launching new products. 

List of Market Players Profiled

• Global Life Technologies (U.S.)
• PDI Healthcare (U.S.)
• 3M (U.S.)
• Clorox Healthcare (U.S.)
• Medline (U.S.)
• GSK (U.K.)
• Teva (Israel)
• Glenmark Pharms (India)
• SmithKline & French (U.K.)
• Taro Pharmaceutical (U.S.)
• Perrigo (Ireland)

REPORT COVERAGE

An overview of the product is provided along with the product description. Numerous industry elements are included in the research. The market insights are prepared by utilizing large sample sizes for data-gathering modules. The study provides in-depth market insights. The stage includes gathering market data or related data using a variety of sources and tactics. It involves going over and organizing all the information gathered during the previous advance. It also covers the investigation of information discrepancies found across various information sources. Market statistical and coherent models are used to assess and estimate market data.